TLD-1433
TLD-1433 is a ruthenium (II)-based water-soluble photodynamic compound. TLD-1433 inactivates enveloped viruses by inducing lipid peroxidation. TLD-1433 inactivates a variety of human pathogenic enveloped and non-enveloped viruses. TLD-1433 can be used in the research of viral infections and BCG-unresponsive non-muscle invasive bladder cancer.
For research use only. We do not sell to patients.
- CAS No.: 1471479-22-7
- Formula: C49H38Cl2N8RuS3
- Molecular Weight:1007.05
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
TLD-1433 inactivates Influenza A virus H1N1, human coronavirus OC-43, and Zika virus in a concentration-dependent manner, with photo-activation drastically reducing effective doses (ED50 values of 9.2 nM, 3.3 nM, and 12.0 nM respectively) compared to dark treatment[1].
TLD-1433 inactivates herpes simplex virus type 1 and Vaccinia virus in a concentration-dependent manner, with photo-activation reducing effective doses (ED50 values of 2.4 nM and 92.3 nM respectively) compared to dark treatment[1].
TLD-1433 inactivates adenovirus type 5 and mammalian orthoreovirus type 1 Lang in a concentration-dependent manner, with photo-activation reducing effective doses (ED50 values of 1.8 μM and 5.4 μM respectively) compared to dark treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1471479-22-7
-
Molecular Weight 1007.05
-
Formula C49H38Cl2N8RuS3
-
SMILES
CC1=CC=[N](C2=C1)[Ru+2]([N]3=CC=C4)([N](C5=C6)=CC=C6C)([N](C5=C7)=CC=C7C)([N](C2=C8)=CC=C8C)[N]9=CC=CC%10=C9C3=C4C%11=C%10NC(C%12=CC=C(C%13=CC=C(C%14=CC=CS%14)S%13)S%12)=N%11.[Cl-].[Cl-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- TLD-1433
- 1471479-22-7
- TLD1433
- TLD 1433
- Reactive Oxygen Species (ROS)
- Influenza Virus
- SARS-CoV
- HSV
- Vaccinia virus
- human pathogenic enveloped viruses
- non-enveloped viruses
- Influenza A virus H1N1
- human coronavirus OC-43
- Zika virus
- bladder tumor
- lipid peroxidation
- herpes simplex virus type 1
- adenovirus type 5
- Inhibitor
- inhibitor
- inhibit